SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 29, 2004
AMERICAN BIO MEDICA CORPORATION
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
--------------------------------------------------------------------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
ITEM 5. OTHER MATTERS
On July 29, 2004, the Registrant's Board of Directors appointed Carl A.
Florio to its Board of Directors.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
The following exhibits are filed with this report on Form 8-K:
99.1 American Bio Medica Corporation press release dated August 9, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION
(Registrant)
Dated: August 9, 2004 By: /s/ Keith E. Palmer
----------------------------
Keith E. Palmer
Chief Financial Officer
Exhibit Index
Exhibit No. Description Page No.
----------- ----------- --------
99.1 Press Release dated August 9, 2004 5